PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vall d\'Hebron Barcelona Hospital Campus, Barcelona, Spain.\', \'Universidad Veracruzana/Instituto de Investigaciones Cerebrales, Xalapa, Veracruz, Mexico. garanda@uv.mx.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s43440-021-00231-5
?:hasPublicationType
?:journal
  • Pharmacological reports : PR
is ?:pmid of
?:pmid
?:pmid
  • 33604795
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all